Medical center Asclepion humane medicine researches EOOD
- Address
- Ulitsa Damyan Gruev 8a, 1303 Sofia, Bulgaria
Medical Center Asclepion Humane Medicine EOOD - Inflammatory Bowel Disease Research
Medical Center Asclepion Humane Medicine EOOD is a specialized research facility dedicated to advancing treatment options for patients with ulcerative colitis and other inflammatory bowel diseases. The center focuses on evaluating novel therapeutics and biosimilar medications across the full spectrum of disease severity, from mild to severe presentations.
- Phase 2 and Phase 3 trials of innovative biologic therapies and novel oral formulations for ulcerative colitis
- Biosimilar equivalence studies comparing new agents to established reference products
- Comprehensive evaluation of clinical remission, endoscopic response, and long-term safety outcomes
The research center demonstrates particular expertise in conducting complex double-blind, placebo-controlled trials that assess both induction therapy and maintenance treatment strategies. Their clinical trial portfolio includes studies of various therapeutic modalities, including subcutaneous biologics, oral mesalazine formulations, and investigational compounds, with rigorous endpoints measuring clinical remission, symptomatic improvement, and endoscopic healing in patients with moderate to severe active disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 of 2 therapeutic areas and 15 of 21 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical center Asclepion humane medicine researches EOOD
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy, Safety, and Immunogenicity of Intravenous AVT16 Versus Vedolizumab in Adults with Moderate to Severe Active Ulcerative Colitis | Alvotech Swiss AG | Phase III | Not Recruiting | Aug 2025 | Oct 2025 |
IMP list
lock Showing 1 of 21 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bacilli, Cluster Xviii, Strain Relative Thomasclavelia Ramosum, Live | 1 | Unknown | 2023-05-11 | 2023-05-11 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.